Company Profile

Synexus Clinical Research GmbH

Profile date: 2025-07-13

Synexus Clinical Research: A Global Network of Dedicated Clinical Trial Sites

Synexus Clinical Research GmbH, as part of a larger global entity, is a leading Site Management Organization (SMO) that operates a worldwide network of dedicated and highly experienced clinical research sites. The company's core business is to professionally manage and conduct clinical trials on behalf of pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs). A key part of the PPD clinical research business of Thermo Fisher Scientific, Synexus functions as a critical piece of infrastructure in the drug development process, specializing in patient recruitment and the efficient execution of late-stage (Phase II-IV) clinical studies across a wide range of therapeutic areas.

What Synexus actually does is bridge the gap between pharmaceutical sponsors who need to test new medicines and the patient volunteers who are essential for this research. Instead of relying on busy hospitals or private practices to conduct trials as a secondary activity, Synexus establishes its own dedicated research centers. These sites are purpose-built for clinical research, staffed with full-time, specially trained doctors, nurses, and support personnel, and equipped with the necessary medical and administrative infrastructure. This dedicated site model allows for a focus on quality, speed, and efficiency in patient enrollment and data collection, which are often major bottlenecks in clinical development.

Please note: This information is generated by AI. For legal use, verify with company sources.